FDA Revokes EUA for Johnson & Johnson/Janssen’s COVID Vaccine
On June 1, 2023, the U.S. Food and Drug Administration (FDA) withdrew the Emergency Use Authorization (EUA) Johnson & Johnson/Janssen’s adenovirus vectored Ad26.COV2.S (also known as JNJ-78436735) COVID-19 vaccine that had been granted to the companies on Feb. 27, 2021. The FDA noted that Janssen requested the voluntary withdrawal of the EUA in a letter […]
More Women Bearing the Brunt of COVID Vaccine Reactions and Injury
Early reports to the Vaccine Adverse Event Reporting System (VAERS), a centralized federally operated vaccine reaction reporting system, after the messenger RNA (mRNA) COVID-19 shots were distributed under an Emergency Use Authorization (EUA in the United States revealed that women were reported to have experienced more severe allergic reactions to the COVID-19 shots than men. […]
U.S. to Spend Billions on New COVID Vaccines Despite Failure to Prevent Infection
The Biden administration announced earlier this month that the U.S. government will spend at least $5 billion on Project NextGen to rapidly develop “next-generation” SARS-CoV-2 vaccines and treatments despite evidence that current COVID vaccines do not prevent infection and transmission of the new coronavirus.1 Following a similar approach to “Operation Warp Speed” initiated by the […]
Birth Rates Plummet in Countries Most Heavily Vaccinated Against COVID-19
A team of European researchers have determined that birth rates in 19 European countries declined sharply toward the end of 2021 following peak COVID-19 vaccine uptake earlier that year in the spring. The research, compiled in August 2022, found that decreased birth rate patterns persisted all of the countries represented in the data, including Germany, […]
CDC Adds COVID Shots to Recommended Vaccine Schedules for Children and Adults
The U.S. Centers for Disease Control and Prevention (CDC) has updated recommended vaccine schedules for children, adolescents and adults to include the COVID-19 biologics. The move is consistent with recommendations made by the agency’s Advisory Committee on Vaccine Practices (ACIP) in October 2022.1 2 3 4 5 The update of the recommended vaccination schedules was […]
Government Buys 1.5 Million More Doses of Novavax’s COVID Vaccine
Biotechnology company Novavax announced that it has made a modification to an existing contract with the U.S. Department of Health and Human Services (HHS) and the Department of Defense (DoD) to provide up to 1.5 million more doses of its Nuvaxovid COVID-19 vaccine (also known as “NVX-CoV2373” and “Covovax”), in addition to the 3.2 million […]
